OP0167 A low molecular weight baff signallinginhibitor, bik-13, ameliorates b cell activation in vit...
OP0167 A low molecular weight baff signallinginhibitor, bik-13, ameliorates b cell activation in vitro and in vivo autoimmune models and consequently suppresses production of igg and cytokines
About this item
Full title
Author / Creator
Yoshimoto, K. , Seki, N. , Suzuki, K. , Sugahara, K. , Chiba, K. and Takeuchi, T.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundWe reported that BAFF robustly increases IL-6 production by peripheral monocytes of patients with primary Sjögren’s syndrome (pSS) and that the BAFF-induced IL-6 production and serum IgG levels of the patients were positively correlated with the expression level of a BAFF receptor (BR3) in pSS monocytes. Moreover, we found that IgG produc...
Alternative Titles
Full title
OP0167 A low molecular weight baff signallinginhibitor, bik-13, ameliorates b cell activation in vitro and in vivo autoimmune models and consequently suppresses production of igg and cytokines
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071228027
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071228027
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.4132
